• No results found

VU Research Portal

N/A
N/A
Protected

Academic year: 2021

Share "VU Research Portal"

Copied!
2
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

VU Research Portal

Nutrition and metabolic profiles in Alzheimer's disease

de Leeuw, F.A.

2020

document version

Publisher's PDF, also known as Version of record

Link to publication in VU Research Portal

citation for published version (APA)

de Leeuw, F. A. (2020). Nutrition and metabolic profiles in Alzheimer's disease.

General rights

Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. • Users may download and print one copy of any publication from the public portal for the purpose of private study or research. • You may not further distribute the material or use it for any profit-making activity or commercial gain

• You may freely distribute the URL identifying the publication in the public portal ?

Take down policy

If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.

E-mail address:

vuresearchportal.ub@vu.nl

(2)

548907-L-bw-de Leeuw 548907-L-bw-de Leeuw 548907-L-bw-de Leeuw 548907-L-bw-de Leeuw Processed on: 5-10-2020 Processed on: 5-10-2020 Processed on: 5-10-2020

Processed on: 5-10-2020 PDF page: 5PDF page: 5PDF page: 5PDF page: 5

Table of contents

Chapter 1 General introduction and thesis outline 7

Chapter 2 Nutrition and neuropathology 21

Chapter 2.1 Brain tocopherol levels are associated with lower activated

microglia density in elderly human cortex 23

Chapter 2.2 Brain γ-tocopherol levels are associated with presynaptic

protein levels in elderly human midfrontal cortex 43

Chapter 3 Metabolic profiles in Alzheimer’s disease 9

Chapter 3.1 Blood-based metabolic signatures in Alzheimer’s disease 61 Chapter 3.2 Circulating metabolites are associated with brain atrophy

and white matter hyperintensities 87

Chapter 4 Nutritional biomarkers and clinical progression in

Alzheimer’s disease 107

Chapter 4.1 Associations between nutrient intake and corresponding nutritional biomarker levels in a memory clinic cohort: the NUDAD project

109 Chapter 4.2 Specific nutritional biomarker profiles in mild cognitive

impairment and subjective cognitive decline are associated with clinical progression: the NUDAD project

133 Chapter 4.3 LDL cholesterol and uridine levels in blood are potential

nutritional biomarkers for clinical progression in Alzheimer’s disease: the NUDAD project

169

Chapter 5 Summary and general discussion 193

Appendix 209

Nederlandse samenvatting 210

List of author affiliations 222

List of publications 226

Dissertations Alzheimer Center Amsterdam 230

Dankwoord 234

Referenties

GERELATEERDE DOCUMENTEN

(2012:603) further comment that the declarations about creativity and scientific creativity particularly need to be considered, given that expressions which include “creative

The average temperature was determined from about 50 to 1 00 reflectance measurements per sample whilst the surface temperature (i.e. temperature on the surface of

Samples were analysed after incubation to determine the amount of hemolysis, cell aggregation or complement activation via the alternative pathway the particles caused,

1) Moral transformative leadership, a leadership-model that implements a social justice agenda by public intellectuals. Scholars in the field of social justice

Using such a metabolomics approach, we were able to prove that a modified Bligh-Dyer extraction method, followed by GC-MS fatty acid metabolome analysis and

As shown in figure 3.6, the 8-sulfinylcaffeine analogues, 6a–b, and the 8-sulfonylcaffeine, 7, were synthesized by reacting an appropriate 8-sulfanylcaffeine

Engelbrecht (2010:12-13) stated that “integrated reporting is not merely slapping two reports together (one financial, one.. THE SUSTAINABILITY OF DONOR FUNDED PROJECTS IN

In summary, restoring dopaminergic function is mainly focused on the treatment with L-DOPA, the dopamine precursor, and with dopamine agonists.. Unfortunately these treatment